bioRxivPharmacology & ToxicologyPreprint
Overexpressed microrna-129-5p reverses CCl4-Induced hepatic fibrosis by suppressing PEG3 expression and the NF-κB signaling pathway
Abstract
The authors have withdrawn their manuscript whilst they perform additional experiments to test some of their conclusions further. This preprint does not represent the final version. Therefore, the authors do not wish this work to be cited as reference for the project.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nanchangmycin regulates FYN, FAK and ERK to control the fibrotic activity of hepatic stellate cells
W. Li, J. Y. Chen, … A. C. Mullen·bioRxiv·Oct 8, 2021
- Aspartate reduces liver inflammation and fibrosis by suppressing the NLRP3 inflammasome pathway via upregulating NS3TP1 expression
Li Zhou, Jing Zhao, … Jun Cheng·Journal of Personalized MedicinePeer-reviewed·Feb 22, 2023
- The hepatocyte Epidermal Growth Factor Receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche
E. Gonzalez-Sanchez, J. Vaquero, … I. Fabregat·bioRxiv·Nov 3, 2023
- Fibrosis resolution in the mouse liver: role of Mmp12 and potential role of Calpain 1/2
T. Sato, K. Z. Head, … G. E. Arteel·bioRxiv·Feb 15, 2022
- Leronlimab a humanized anti-CCR5 monoclonal antibody ameliorates hepatic fibrosis in two preclinical fibrosis mouse models
Melissa Palmer, Taishi Hashiguchi, … Jacob Paul Lalezari·ASEAN Journal of PsychiatryPeer-reviewed·Jan 1, 2026
- METTL3 facilitates hepatic fibrosis progression via m6A-YTHDF2 dependent silencing of GPR161
Xue‐Yin Pan, Yihui Bi, … Jun Li·bioRxiv·Dec 15, 2021